2020 Targeting ALK - From Discovery to Frontline Treatment
6 Mga view
• 07/30/23
0
0
I-embed
administrator
Mga subscriber
In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento